181 related articles for article (PubMed ID: 31585907)
21. Technologies for detection of circulating tumor cells: facts and vision.
Alix-Panabières C; Pantel K
Lab Chip; 2014 Jan; 14(1):57-62. PubMed ID: 24145967
[TBL] [Abstract][Full Text] [Related]
22. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells in oral squamous cell carcinoma: An insight.
Prakruthi BV; Babu NC
Indian J Cancer; 2015; 52(2):232-4. PubMed ID: 26853418
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumor cells in the clinical cancer diagnosis.
Zhang P; Zhou H; Lu K; Wang Y; Feng T
Clin Transl Oncol; 2020 Mar; 22(3):279-282. PubMed ID: 31140068
[TBL] [Abstract][Full Text] [Related]
25. Detection of Circulating Tumor Cells (CTCs) in Patients with Testicular Germ Cell Tumors.
Nastały P; Honecker F; Pantel K; Riethdorf S
Methods Mol Biol; 2021; 2195():245-261. PubMed ID: 32852768
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
28. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
29. Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
Tsutsuyama M; Nakanishi H; Yoshimura M; Oshiro T; Kinoshita T; Komori K; Shimizu Y; Ichinosawa Y; Kinuta S; Wajima K; Sakakibara Y; Yatabe Y; Ito S; Kodera Y
PLoS One; 2019; 14(2):e0212221. PubMed ID: 30811434
[TBL] [Abstract][Full Text] [Related]
30. Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
Bang-Christensen SR; Pedersen RS; Pereira MA; Clausen TM; Løppke C; Sand NT; Ahrens TD; Jørgensen AM; Lim YC; Goksøyr L; Choudhary S; Gustavsson T; Dagil R; Daugaard M; Sander AF; Torp MH; Søgaard M; Theander TG; Østrup O; Lassen U; Hamerlik P; Salanti A; Agerbæk MØ
Cells; 2019 Aug; 8(9):. PubMed ID: 31466397
[TBL] [Abstract][Full Text] [Related]
31. Size-based separation methods of circulating tumor cells.
Hao SJ; Wan Y; Xia YQ; Zou X; Zheng SY
Adv Drug Deliv Rev; 2018 Feb; 125():3-20. PubMed ID: 29326054
[TBL] [Abstract][Full Text] [Related]
32. Circulating Tumor Cells: Markers and Methodologies for Enrichment and Detection.
Alvarez Cubero MJ; Lorente JA; Robles-Fernandez I; Rodriguez-Martinez A; Puche JL; Serrano MJ
Methods Mol Biol; 2017; 1634():283-303. PubMed ID: 28819860
[TBL] [Abstract][Full Text] [Related]
33. Sensitive and easy screening for circulating tumor cells by flow cytometry.
Lopresti A; Malergue F; Bertucci F; Liberatoscioli ML; Garnier S; DaCosta Q; Finetti P; Gilabert M; Raoul JL; Birnbaum D; Acquaviva C; Mamessier E
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31194699
[TBL] [Abstract][Full Text] [Related]
34. Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness.
Caceres G; Puskas JA; Magliocco AM
Cancer Control; 2015 Apr; 22(2):167-76. PubMed ID: 26068761
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biological significance of circulating tumor cells in cancer.
Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
37. EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.
Soler A; Cayrefourcq L; Mazel M; Alix-Panabières C
Methods Mol Biol; 2017; 1634():263-276. PubMed ID: 28819858
[TBL] [Abstract][Full Text] [Related]
38. Microfluidic applications on circulating tumor cell isolation and biomimicking of cancer metastasis.
Xu X; Jiang Z; Wang J; Ren Y; Wu A
Electrophoresis; 2020 Jun; 41(10-11):933-951. PubMed ID: 32144938
[TBL] [Abstract][Full Text] [Related]
39. Epithelial-mesenchymal transition markers expressed in circulating tumor cells in hepatocellular carcinoma patients with different stages of disease.
Li YM; Xu SC; Li J; Han KQ; Pi HF; Zheng L; Zuo GH; Huang XB; Li HY; Zhao HZ; Yu ZP; Zhou Z; Liang P
Cell Death Dis; 2013 Oct; 4(10):e831. PubMed ID: 24091674
[TBL] [Abstract][Full Text] [Related]
40. Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence.
Garcia J; Barthelemy D; Geiguer F; Ballandier J; Li KW; Aurel JP; Le Breton F; Rodriguez-Lafrasse C; Manship B; Couraud S; Payen L
J Vis Exp; 2019 Aug; (150):. PubMed ID: 31475991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
